Literature DB >> 18080952

Erythropoietin induces a shift of muscle phenotype from fast glycolytic to slow oxidative.

J-L Cayla1, P Maire, A Duvallet, J P Wahrmann.   

Abstract

Sedentary and trained rat groups were studied. Each of these groups was either erythropoietin or placebo treated. Erythropoietin treatment increased significantly all haematological parameters studied. Training per se failed to modify haematological parameters. In a second time, we studied the specific activity of several oxidative enzymes in three different muscles. In sedentary rats, erythropoietin treatment increased significantly the specific activities of cytochrome c oxidase and L-3-hydroxyacyl CoA dehydrogenase in the soleus and those of L-3-hydroxyacyl CoA dehydrogenase and phosphofructokinase in both locomotor muscles. Training increased the oxidative enzymes activities in all muscles studied. In trained rats, effects of erythropoietin and training on oxidative enzymes activities were additive. In all erythropoietin treated muscles, the expression of slow twitch myosin light chains and oxidative myosin heavy chains increased. A similar phenomenon took place in all trained groups for light chains and in placebo treated trained rats for heavy chains. In trained groups, the effects of the hormone and of training were additive. Our results suggest strongly that two different mechanisms are involved in the response of skeletal muscles to erythropoietin treatment and to endurance training and probably whole body endurance is affected by erythropoietin treatment by an increase of oxygenation of all tissues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18080952     DOI: 10.1055/s-2007-965359

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  17 in total

1.  Three weeks of erythropoietin treatment hampers skeletal muscle mitochondrial biogenesis in rats.

Authors:  Vladimir E Martinez-Bello; Fabian Sanchis-Gomar; Marco Romagnoli; Frederic Derbre; Mari Carmen Gomez-Cabrera; Jose Viña
Journal:  J Physiol Biochem       Date:  2012-05-25       Impact factor: 4.158

2.  RhEPO improves time to exhaustion by non-hematopoietic factors in humans.

Authors:  Simon Annaheim; Matthias Jacob; Alexander Krafft; Christian Breymann; Markus Rehm; Urs Boutellier
Journal:  Eur J Appl Physiol       Date:  2016-01-04       Impact factor: 3.078

3.  Skeletal muscle intrinsic functional properties are preserved in a model of erythropoietin deficient mice exposed to hypoxia.

Authors:  Luciana Hagström; Francis Canon; Onnik Agbulut; Dominique Marchant; Bernard Serrurier; Jean-Paul Richalet; Michèle Beaudry; Xavier Bigard; Thierry Launay
Journal:  Pflugers Arch       Date:  2010-01-30       Impact factor: 3.657

4.  Erythropoietin contributes to slow oxidative muscle fiber specification via PGC-1α and AMPK activation.

Authors:  Li Wang; Yi Jia; Heather Rogers; Norio Suzuki; Max Gassmann; Qian Wang; Alexandra C McPherron; Jeffery B Kopp; Masayuki Yamamoto; Constance Tom Noguchi
Journal:  Int J Biochem Cell Biol       Date:  2013-03-20       Impact factor: 5.085

5.  A non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice.

Authors:  M Collino; E Benetti; M Rogazzo; F Chiazza; R Mastrocola; D Nigro; J C Cutrin; M Aragno; R Fantozzi; M A Minetto; C Thiemermann
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

6.  Blunting effect of hypoxia on the proliferation and differentiation of human primary and rat L6 myoblasts is not counteracted by Epo.

Authors:  T Launay; L Hagström; S Lottin-Divoux; D Marchant; P Quidu; F Favret; A Duvallet; T Darribère; J P Richalet; M Beaudry
Journal:  Cell Prolif       Date:  2010-02       Impact factor: 6.831

7.  Association of the VEGFR2 gene His472Gln polymorphism with endurance-related phenotypes.

Authors:  Ildus I Ahmetov; Albina M Hakimullina; Daniil V Popov; Ekaterina V Lyubaeva; Svetlana S Missina; Olga L Vinogradova; Alun G Williams; Viktor A Rogozkin
Journal:  Eur J Appl Physiol       Date:  2009-06-12       Impact factor: 3.078

8.  Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophy.

Authors:  Martin Köllensperger; Florian Krismer; Anton Pallua; Nadia Stefanova; Werner Poewe; Gregor K Wenning
Journal:  Mov Disord       Date:  2011-01-06       Impact factor: 10.338

9.  Erythropoietin over-expression protects against diet-induced obesity in mice through increased fat oxidation in muscles.

Authors:  Pernille Hojman; Camilla Brolin; Hanne Gissel; Claus Brandt; Bo Zerahn; Bente Klarlund Pedersen; Julie Gehl
Journal:  PLoS One       Date:  2009-06-12       Impact factor: 3.240

10.  Satellite cell response to erythropoietin treatment and endurance training in healthy young men.

Authors:  Andrea Hoedt; Britt Christensen; Birgitte Nellemann; Ulla Ramer Mikkelsen; Mette Hansen; Peter Schjerling; Jean Farup
Journal:  J Physiol       Date:  2015-12-30       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.